|
Recent Developments |
|
11-OCT-18
Merck announced that the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, by a letter dated October 08, 2018, has approved the proposal dated May 31, 2018 of Procter & Gamble Overseas India B.V. for acquisition of up to 77.80% of the paid-up
13-MAY-14
ICRA has reaffirmed 'AA' to the enhanced Rs 307.5 million fund based and Rs 135 million non-fund based bank limits of Merck. The outlook on th... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 30-Sep-2015(9) | 31-Dec-2014 (12) | 31-Dec-2013 (12) | | Net sales | 6763.40 | 8324.48 | 7729.62 | | Other Income | 164.52 | 203.34 | 214.48 | | Total Income | 6927.92 | 8527.82 | 7944.10 | | Cost of goods sold | 6435.94 | 8085.81 | 7209.12 | | OPBDIT | 491.98 | 442.01 | 734.98 | | PAT | 389.94 | 432.24 | 558.76 | | Gross Block | - | - | - | | Equity capital | 165.99 | 165.99 | 165.99 | | EPS (Rs.) | - | 26.04 | 33.66 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 20.58 - 35.28 | 15.53 - 20.47 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 7.1 | 5.2 | 9.3 | | Net margin (% of OI) | 5.6 | 5.1 | 7.0 |
|
|
Detailed Financials
|
|
|
|
|
